Search - tctmd.com

Displaying 101 - 120 of 414

Sort: Relevancy | Date

Ticagrelor’s Dominance Over Clopidogrel Again Questioned

News Daily News

Ticagrelor’s Dominance Over Clopidogrel Again Questioned

April 16, 2021

Dual Bests Triple Therapy in Nonvalvular AF Patients in RE-DUAL PCI

News Daily News

Dual Bests Triple Therapy in Nonvalvular AF Patients in RE-DUAL PCI

Yael L. Maxwell

April 09, 2021

New Antithrombotic Revacept Fails to Reduce Myocardial Injury in PCI

News Daily News

New Antithrombotic Revacept Fails to Reduce Myocardial Injury in PCI

Yael L. Maxwell

April 05, 2021

Antithrombotics for Elderly CAD Patients: One Size Doesn’t Fit All

News Daily News

Antithrombotics for Elderly CAD Patients: One Size Doesn’t Fit All

April 05, 2021

Meta-analysis Supports Genotype-Guided P2Y12 Prescription for ACS

News Daily News

Meta-analysis Supports Genotype-Guided P2Y12 Prescription for ACS

Yael L. Maxwell

March 25, 2021

Platelet Tests Pre-CABG May Safely Shorten Washout Waits, Cut Costs

News Daily News

Platelet Tests Pre-CABG May Safely Shorten Washout Waits, Cut Costs

Yael L. Maxwell

March 09, 2021

EVOLVE Short DAPT in Print: P2Y12 Decisions Can Safely Be Made Case-by-Case

News Daily News

EVOLVE Short DAPT in Print: P2Y12 Decisions Can Safely Be Made Case-by-Case

Yael L. Maxwell

March 03, 2021

Experts Update Antithrombotic Advice in AF Patients Undergoing PCI

News Daily News

Experts Update Antithrombotic Advice in AF Patients Undergoing PCI

February 09, 2021

February 2021 News Roundup

News Opinion CV Team Dispatch

February 2021 News Roundup

February 01, 2021

ACC Issues New Guidance Around Antithrombotic Choices in A-fib, VTE

News Daily News

ACC Issues New Guidance Around Antithrombotic Choices in A-fib, VTE

December 22, 2020

Routine Use of GRACE Score Doesn’t Improve ACS Management: AGRIS

News Daily News

Routine Use of GRACE Score Doesn’t Improve ACS Management: AGRIS

December 16, 2020

More Women Than Men Develop HF or Die After STEMI

News Daily News

More Women Than Men Develop HF or Die After STEMI

December 01, 2020

Clopidogrel Should Remain Antiplatelet of Choice in Elective PCI: ALPHEUS

News Conference News AHA 2020

Clopidogrel Should Remain Antiplatelet of Choice in Elective PCI: ALPHEUS

Michael O'Riordan

November 14, 2020

News Daily News

Fewer MIs With Prasugrel Than Ticagrelor in STEMI Patients: ISAR-REACT 5

Michael O'Riordan

November 03, 2020

Superiority of Ticagrelor Over Clopidogrel in ACS Questioned

News Daily News

Superiority of Ticagrelor Over Clopidogrel in ACS Questioned

October 29, 2020

Shorter DAPT Succeeds in Xience-Treated Patients at High Bleeding Risk

News Conference News TCT 2020

Shorter DAPT Succeeds in Xience-Treated Patients at High Bleeding Risk

October 15, 2020

Bivalirudin vs Heparin Patient-Level Meta-analysis Stirs an Old Debate

News Conference News TCT 2020

Bivalirudin vs Heparin Patient-Level Meta-analysis Stirs an Old Debate

October 14, 2020

Ticagrelor Monotherapy Following 3-Month DAPT Cuts Post-PCI Bleeding After STEMI

News Conference News TCT 2020

Ticagrelor Monotherapy Following 3-Month DAPT Cuts Post-PCI Bleeding After STEMI

October 14, 2020

No Reperfusion Benefit From Crushed Prasugrel Prior to PCI: COMPARE CRUSH

News Conference News TCT 2020

No Reperfusion Benefit From Crushed Prasugrel Prior to PCI: COMPARE CRUSH

October 14, 2020

TCT 065: Cangrelor Use Patterns and Transition to Oral P2Y12 Inhibitors Among Patients With Myocardial Infarction: Early Results From the Cangrelor in Acute Myocardial Infarction: Effectiveness and Outcomes (CAMEO) Registry

Presentation TCT 2020

TCT 065: Cangrelor Use Patterns and Transition to Oral P2Y12 Inhibitors Among Patients With Myocardial Infarction: Early Results From the Cangrelor in Acute Myocardial Infarction: Effectiveness and Outcomes (CAMEO) Registry

Presenter: Jennifer Rymer

October 14, 2020

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.